Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR2 | O15552 | 1/20 | 0.38 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.34 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.34 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.34 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30336577 | 0.98 | FFAR2 (0.38) | FFAR2CSNK2A2CSNK2BCSNK2A1CSNK2A3 | |
| SCHEMBL15836949 | 0.70 | — | — | |
| SCHEMBL13024156 | 0.67 | FFAR2 (0.58) | FFAR2CSNK2A2CSNK2BCSNK2A1CSNK2A3 | |
| SCHEMBL22402426 | 0.67 | FFAR2 (0.38) | FFAR2CSNK2A2CSNK2BCSNK2A1CSNK2A3 | |
| SCHEMBL211122 | 0.66 | — | — | |
| SCHEMBL22660990 | 0.66 | FFAR2 (0.43) | FFAR2CSNK2A2CSNK2BCSNK2A1CSNK2A3 | |
| SCHEMBL9790744 | 0.66 | FDPS (0.49) | — | |
| SCHEMBL28438130 | 0.65 | FFAR2 (0.37) | FFAR2CSNK2A2CSNK2BCSNK2A1CSNK2A3 | |
| Hydrochloric Acid SCHEMBL243026 | 0.65 | — | — | |
| SCHEMBL28986886 | 0.63 | FFAR2 (0.35) | FFAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111417462-B | Catalyst system and ethylene oligomerization process | 切弗朗菲利浦化学公司 | 2023-04-18 | — | — | CN | disclosed |
| US-10807921-B2 | Catalyst systems and ethylene oligomerization method | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2020-10-20 | — | — | US | disclosed |
| EP-3717119-A1 | CATALYST SYSTEMS AND ETHYLENE OLIGOMERIZATION METHOD | Chevron Phillips Chemical Company LP (US) | 2020-10-07 | — | — | EP | disclosed |
| CN-111417462-A | Catalyst system and ethylene oligomerization process | 切弗朗菲利浦化学公司 | 2020-07-14 | — | — | CN | disclosed |
| US-20190169086-A1 | Catalyst Systems and Ethylene Oligomerization Method | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2019-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190169086-A1 | Catalyst Systems and Ethylene Oligomerization Method | MAX, NOD2, NOD1 | FFAR2 4673/4885CSNK2A2 3356/4885CSNK2B 3387/4885 |
| US-10807921-B2 | Catalyst systems and ethylene oligomerization method | MAX, NOD2, NOD1 | FFAR2 4673/4885CSNK2A2 3356/4885CSNK2B 3387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.